ProfoundBio is a clinical stage biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on innovative technology platforms, ProfoundBio has developed a pipeline consisting of multiple candidates that are currently in discovery, preclinical development, and clinical stage targeting of a broad range of tumors.